Financhill
Back

GH Research PLC Quote, Financials, Valuation and Earnings

GH Research PLC Price Quote

$9.53
-0.09 (-0.94%)
(Updated: November 22, 2024 at 1:20 PM ET)

GH Research PLC Key Stats

Buy
57
GH Research PLC (GHRS) is a Buy

Day range:
$9.45 - $11.07
52-week range:
$5.05 - $14.99
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
2.64%

Volume:
103.6K
Avg. volume:
66.9K
1-year change:
64.44%
Market cap:
$500.5M
Revenue:
$0
EPS:
$-0.79

How Much Does GH Research PLC Make?

Data Unavailable

Is GH Research PLC Growing As A Company?

Data Unavailable

GH Research PLC Stock Price Performance

  • Did GH Research PLC Stock Go Up Last Month?
    GH Research PLC share price went up by 15.9% last month
  • Did GHRS's Share Price Rise Over The Last Year?
    GHRS share price rose by 64.44% over the past 1 year

What Is GH Research PLC 52-Week High & Low?

GH Research PLC Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy GH Research PLC?

  • How Much Debt Does GH Research PLC Have?
    Total long term debt quarterly is $0
  • How Much Cash Does GH Research PLC Have?
    Cash and short term investments quarterly total is $150M
  • What Is GH Research PLC’s Book Value Per Share?
    Book value per share is 3.64

Is GH Research PLC Cash Flow Positive?

  • What Is GHRS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$39.9M
  • What Is GH Research PLC’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$286K
  • What Is GH Research PLC’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $43.8M

GH Research PLC Return On Invested Capital

Data Unavailable

GH Research PLC Earnings Date & Stock Price

GH Research PLC Competitors

  • Who Are GH Research PLC's Competitors?
    Below is a list of companies who compete with GH Research PLC or are related in some way:
    • Amarin Corp PLC (AMRN)
    • Iterum Therapeutics PLC (ITRM)
    • Jazz Pharmaceuticals PLC (JAZZ)
    • Mural Oncology PLC (MURA)
    • Prothena Corp PLC (PRTA)

GH Research PLC Dividend Yield

GH Research PLC Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 8.91%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 31.25
Upside from Last Price: 224.84%

Major Shareholders

  • How many GHRS shares are owned by institutional investors?
    29.8M GHRS shares are owned by institutional investors
  • How many GHRS shares are owned by insiders?
    0 GHRS shares are owned by insiders